Multimorbidity, glycaemic variability and time in target range in people with type 2 diabetes: A baseline analysis of the GP-OSMOTIC trial
Diabetes Research and Clinical Practice Sep 20, 2020
Chiang JI, Manski-Nankervis JA, Thuraisingam S, et al. - Researchers conducted this cross-sectional study to explore correlations between multimorbidity condition counts (total; concordant (diabetes-related); discordant (unrelated to diabetes)) and glycaemia (HbA1c; glycaemic variability (GV); time in range (TIR)) using data from a randomised controlled trial investigating the effectiveness of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D). Two hundred seventy-nine people, mean (SD) age 60.4 (9.9) years, with T2D using baseline data from the General Practice Optimising Structured MOnitoring To Improve Clinical outcomes (GP-OSMOTIC) trial from 25 general practices in Australia. No proof of interaction between multimorbidity counts, HbA1c, GV and TIR. Although multimorbidity was common in this T2D cohort, it was not linked to HbA1c, CV or TIR.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries